the vaccine , known as rts , s , took 30 years to develop but it is now hoped it can be used to save millions of lives . there is no licensed vaccine against malaria anywhere in the world and researchers say they are hopeful the results will be sufficient for rts , s to gain a licence from the ema.the world health organisation could then recommend its use by october this year . professor brian greenwood , the study’s author and professor of clinical tropical medicine at the london school of hygiene and tropical medicine , said : ‘ despite the falling efficacy over time , there is still a clear benefit from rts , s . ‘ the shot , which is designed to be used by children in africa , could be approved by october , making it the first approved vaccine for the world 's most deadly disease .